Version 7 Sampler E-Bookr

Why Computer Aided   Dosing is so important!

How does the Computer Manage Doses ?

What our Customers Say!

Why Buy Dawn AC?

Existing Customer List

Why Customers Chose Dawn AC

Your Key Objectives

Success Factors

Benefit/Cost Statement

Version 6 Structure

Newsletter

Audit and Benchmarking

Topics in this Dawn AC E-Newsletter              Previous Newsletters

Register to Receive the E-Newsletter Monthly Click Here

Topics in this Dawn AC E-Newsletter

• Mistake Proof Your Service with 'Poka-yokes'

• Predicting The Safest Length of Treatment

• Dawn AC Version 7

• Forthcoming Meetings

Mistake Proof Your Service with 'Poka-yokes'

Are you dealing with the right patient? How do you know you have given the patient the right dose instruction? Have you dealt with all the non-attenders?

A poka-yoke (poka yoke (pronounced "poh-kah yoh-kay") translates into English from Japanese as to avoid (yokeru) inadvertent errors (poka). This concept helped revolutionize quality in Japanese industry in the last decades.

What is it? It is any device or mechanism that either prevents a mistake from being made or makes the mistake obvious at a glance. It stops human error by preventing unsafe acts or unsafe limits being exceeded. They are usually low cost, 'non high tech' things that most people could devise. The principle is to detect problems early and so give alarms or force the stopping of the procedure.

A simple example would the use of window envelopes so the letter can't be sent to the wrong person. The use of checklists to check if something has been missed or omitted or got out of sequence.

Have you any examples you can share? Please let me know.

For more info and examples of poka-yokes, please see the website http://csob.berry.edu/faculty/jgrout/everyday.html

Predicting The Safest Length of Treatment

There are number of areas where advanced computing techniques can be used to help improve decision making especially when the information is not precise on incomplete i.e. fuzzy. Here are a few examples:

• The safest length of treatment for DVT patients

• The diagnosis of DVT/PE

• Selection of the best treatments e.g. in anticoagulation and haemto-oncology

• The best dose adjustments and test Intervals for certain types of patient.

I am currently discussing with Lancaster University collaborative projects to investigate such areas. I ask for your help. If you are interested in of the above subjects or similar ones please let me know.

Dawn AC Version 7

Good progress on the Dawn AC Version 7 is being made. This is based on robust client server technology using a web browser front end with Microsoft SQL Server database.

The system will also be able to support national, regional or district wide access enabling primary, secondary and tertiary care centres to share the same data but subject to compliance with the latest data protection requirements such as HIPPA.

Forthcoming Meetings 

If you are attending the following meetings would be pleased to see you.

British Society of Haematology, Manchester, UK, 11th to 13th April 2005 on Stand 11.

The Anticoagulation Forum, Orlando, Florida, USA, 5th to 7th May 2005.

American Society of Health Systems Pharmacists, Boston, USA, 13th to 15th June 2005 on Booth 551.

International Society of Haemostasis and Thrombosis, Sydney, Australia, 8th to 11th August 2005 on Booth 502.

Syd Stewart

Managing Director

End of Newsletter

“We Really Care"